At a glance
ClinicalIndex Comparison RecordN/ACompleted· 128 enrolled
Drug / intervention
No intervention. Non-interventional studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions In Denmark
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted Feb 2, 2012·Updated Jan 28, 2021
In Brief
An observational study evaluating No intervention. Non-interventional study for Peripheral Neuropathic Pain. Completed, enrolled 128 participants.
Detailed Summary
Observational study to assess the effectiveness and use of pregabalin (Lyrica) in the treatment of patients with peripheral neuropathic pain in real-life daily clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Neuropathic Pain
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
First PostedFeb 2012
Primary CompletionMar 2014
TodayJul 2026
First PostedFeb 2, 2012
Enrollment StartJan 1, 2012
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 14.4 years ago
Interventions
No intervention. Non-interventional studyother
No intervention. Non-interventional study